rs11466334

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000660.7(TGFB1):​c.860+51C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00447 in 1,610,914 control chromosomes in the GnomAD database, including 276 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 133 hom., cov: 31)
Exomes 𝑓: 0.0025 ( 143 hom. )

Consequence

TGFB1
NM_000660.7 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.52

Publications

11 publications found
Variant links:
Genes affected
TGFB1 (HGNC:11766): (transforming growth factor beta 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016]
TGFB1 Gene-Disease associations (from GenCC):
  • Camurati-Engelmann disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • inflammatory bowel disease, immunodeficiency, and encephalopathy
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • cystic fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 19-41341832-G-A is Benign according to our data. Variant chr19-41341832-G-A is described in ClinVar as Benign. ClinVar VariationId is 1261994.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0764 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TGFB1NM_000660.7 linkc.860+51C>T intron_variant Intron 5 of 6 ENST00000221930.6 NP_000651.3
TGFB1XM_011527242.3 linkc.863+51C>T intron_variant Intron 5 of 6 XP_011525544.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TGFB1ENST00000221930.6 linkc.860+51C>T intron_variant Intron 5 of 6 1 NM_000660.7 ENSP00000221930.4

Frequencies

GnomAD3 genomes
AF:
0.0229
AC:
3483
AN:
152184
Hom.:
131
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0786
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00963
Gnomad ASJ
AF:
0.00260
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000426
Gnomad OTH
AF:
0.0196
GnomAD2 exomes
AF:
0.00590
AC:
1469
AN:
249192
AF XY:
0.00441
show subpopulations
Gnomad AFR exome
AF:
0.0774
Gnomad AMR exome
AF:
0.00400
Gnomad ASJ exome
AF:
0.00159
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000366
Gnomad OTH exome
AF:
0.00311
GnomAD4 exome
AF:
0.00254
AC:
3710
AN:
1458612
Hom.:
143
Cov.:
32
AF XY:
0.00223
AC XY:
1615
AN XY:
725700
show subpopulations
African (AFR)
AF:
0.0835
AC:
2790
AN:
33400
American (AMR)
AF:
0.00452
AC:
202
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.00168
AC:
44
AN:
26122
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39684
South Asian (SAS)
AF:
0.000209
AC:
18
AN:
86092
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53252
Middle Eastern (MID)
AF:
0.00640
AC:
27
AN:
4222
European-Non Finnish (NFE)
AF:
0.000295
AC:
328
AN:
1110964
Other (OTH)
AF:
0.00499
AC:
300
AN:
60172
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
199
399
598
798
997
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0229
AC:
3495
AN:
152302
Hom.:
133
Cov.:
31
AF XY:
0.0213
AC XY:
1588
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.0786
AC:
3267
AN:
41556
American (AMR)
AF:
0.00961
AC:
147
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00260
AC:
9
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000426
AC:
29
AN:
68028
Other (OTH)
AF:
0.0194
AC:
41
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
164
328
491
655
819
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00927
Hom.:
67
Bravo
AF:
0.0248
Asia WGS
AF:
0.00606
AC:
21
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
2.1
DANN
Benign
0.80
PhyloP100
-1.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11466334; hg19: chr19-41847737; API